Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för SIS3. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

7 träffar

Bibliografisk träff 2015-07-09

Transforming growth factor-β1 induces type II collagen and aggrecan expression via activation of extracellular signal-regulated kinase 1/2 and Smad2/3 signaling pathways.

Zhu Y, Tao H, Jin C, Liu Y, Lu X, Hu X, Wang X.

Mol Med Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/mmr.2015.4068

Bibliografisk träff 2015-05-07

Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.

Yang H, Zhan L, Yang T, Wang L, Li C, Zhao J, Lei Z, Li X, Zhang HT.

Oncol Rep · research support, non-u.s. gov't; journal article · DOI 10.3892/or.2015.3961

Bibliografisk träff 2015-05-06

Smad3 deficiency protects mice from obesity-induced podocyte injury that precedes insulin resistance.

Sun YB, Qu X, Howard V, Dai L, Jiang X, Ren Y, Fu P, Puelles VG, Nikolic-Paterson DJ, Caruana G, Bertram JF, Sleeman MW, Li J.

Kidney Int · research support, non-u.s. gov't; journal article · DOI 10.1038/ki.2015.121

Bibliografisk träff 2015-03-01

Neovibsanin B increases extracellular matrix proteins in optic nerve head cells via activation of Smad signalling pathway.

Wang Z, Xu W, Rong A, Lin Y, Qiu XL, Qu S, Lan XH.

Int J Clin Exp Pathol · research support, non-u.s. gov't; research-article; journal article

Bibliografisk träff 2014-01-01

Ellagic acid exerts anti-proliferation effects via modulation of Tgf-β/Smad3 signaling in MCF-7 breast cancer cells.

Zhang T, Chen HS, Wang LF, Bai MH, Wang YC, Jiang XF, Liu M.

Asian Pac J Cancer Prev · research support, non-u.s. gov't; journal article · DOI 10.7314/apjcp.2014.15.1.273

Bibliografisk träff 2013-05-21

Smad3 is the key to transforming growth factor-β1-induced osteoclast differentiation in giant cell tumor of bone.

Lou Z, Yang Y, Ren T, Tang S, Peng X, Lu Q, Sun Y, Guo W.

Med Oncol · research support, non-u.s. gov't; journal article · DOI 10.1007/s12032-013-0606-8

Bibliografisk träff 2005-11-15

Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression.

Jinnin M, Ihn H, Tamaki K.

Mol Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1124/mol.105.017483